1. A double‐blind, randomized, placebo‐controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. (1st May 2019) Authors: Werth, V.P.; Merrill, J.T. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A double‐blind, randomized, placebo‐controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus. (26th April 2019) Authors: Werth, V.P.; Merrill, J.T. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0412 Exploratory Results from The Bliss and Illuminate Trials Support The Design of The CHABLIS-SC1 Trial, A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Efficacy and Safety of Blisibimod Administration in Subjects with Systemic Lupus Erythematosus. (15th July 2016) Authors: Merrill, J.T.; Strand, V.; Hislop, C.; Gangal, M.; Martin, R.S.; Kalunian, K.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients With Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study. Issue 4 (December 2016) Authors: Kim, M.Y.; Buyon, J.P.; Guerra, M.M.; Rana, S.; Zhang, D.; Laskin, C.A.; Petri, M.; Lockshin, M.D.; Sammaritano, L.R.; Branch, D.W.; Porter, T.F.; Merrill, J.T.; Stephenson, M.D.; Gao, Q.; Karumanchi, S.A.; Salmon, J.E. Journal: Obstetric anesthesia digest Issue: Volume 36:Issue 4(2016:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients With Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study. Issue 4 (December 2016) Authors: Kim, M.Y.; Buyon, J.P.; Guerra, M.M.; Rana, S.; Zhang, D.; Laskin, C.A.; Petri, M.; Lockshin, M.D.; Sammaritano, L.R.; Branch, D.W.; Porter, T.F.; Merrill, J.T.; Stephenson, M.D.; Gao, Q.; Karumanchi, S.A.; Salmon, J.E. Journal: Obstetric anesthesia digest Issue: Volume 36:Issue 4(2016:Dec.) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0382 Impact of Treatments on Major Immunologic Pathways in SLE Depends on Type I Interferon Signature: Analysis from Biomarkers of Lupus Disease (BOLD) Study. (10th June 2014) Authors: Merrill, J.T.; Immermann, F.W.; Zhou, T.; O'Toole, M.; Whitley, M.; Hill, A.A.; Zhang, Y.; von Schack, D.; Reddy, P.S.; Masferrer, J.L.; Kamp, S.; Guthridge, J.M.; Thanou, A.; Wu, P.; Paradis, T.; Mounts, W.M.; James, J.A.; Sridharan, S.T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0384 Background Treatment and Disease Variables Affecting High Placebo Responses in Systemic Lupus Erythematosus (SLE) Trials: Update from the Soccit Program. (10th June 2014) Authors: Kalunian, K.C.; Kim, M.Y.; Baskaran, A.; Daly, R.P.; Merrill, J.T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0063 Impact of baseline interferon pathway activation on widespread gene expression changes with disease flare in lupus patients: Interim report from the bold (biomarkers of lupus disease) study. (23rd January 2014) Authors: Seyhan, A.; O'Toole, M.; Zhang, Y.; Immermann, F.W.; Hill, A.; Reddy, P.; Masferrer, J.; Zhou, T.; Mounts, W.; Whitley, M.; Walker, T.; Kamp, S.; James, J.; Sridharan, S.; Merrill, J.T.; Honczarenko, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0079 Pharmacodynamic Changes in Gene Expression Observed in Two Phase 3 Trials of Baff Blockade with Tabalumab in SLE. (9th June 2015) Authors: Hoffman, R.; Merrill, J.T.; Alarcόn-Riquelme, M.E.; Petri, M.; Dow, E.R.; Nantz, E.; Nisenbaum, L.K.; Schroeder, K.M.; Komocsar, W.J.; Perumal, N.B.; Rocha, G.V.; Higgs, R.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0251 Attainment of low disease activity and remission in systemic lupus erythematosus patients with high disease activity in the atacicept phase iib address ii study and its long-term extension. (12th June 2018) Authors: Morand, E.; Merrill, J.T.; Isenberg, D.A.; Kao, A.H.; Vazquez–Mateo, C.; Wax, S.; Chang, P.; Pudota, K.; Aranow, C.; Wallace, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗